Jump to navigation
Drug-maker GlaxoSmithKline is going to stop paying doctors worldwide for speaking engagements. And it'll stop setting targets for its drug reps.
Explore Stories that share this feature's tags
Wealth & Poverty Coverage
©2013 American Public Media